InFocus Therapeutics
A second-generation, AI-driven biotechnology company focused on discovery of RNA-targeting small molecules. The organisation combines computational chemistry, cheminformatics, medicinal chemistry, and preclinical biology to advance hit identification through lead optimization and IND-enabling activities.
Industries
Nr. of Employees
small (1-50)
Products
InFocus Artificial Intelligence Discovery Engine
A second-generation AI-powered discovery platform designed to identify differentiated RNA-targeting small molecules faster, integrating scientific rigor with international business development and capital formation.
InFocus Artificial Intelligence Discovery Engine
A second-generation AI-powered discovery platform designed to identify differentiated RNA-targeting small molecules faster, integrating scientific rigor with international business development and capital formation.
Services
Platform service using AI and computational chemistry to discover and prioritize RNA-targeting small molecules and advance early discovery programs.
Services spanning assay development, hit-to-lead progression, lead optimization, in vivo proof-of-concept studies, DMPK/bioanalysis, and IND-enabling planning.
Platform service using AI and computational chemistry to discover and prioritize RNA-targeting small molecules and advance early discovery programs.
Services spanning assay development, hit-to-lead progression, lead optimization, in vivo proof-of-concept studies, DMPK/bioanalysis, and IND-enabling planning.
Expertise Areas
- AI-driven drug discovery
- RNA-targeted small-molecule discovery
- Medicinal chemistry (hit-to-lead and lead optimization)
- Preclinical pharmacology and translational models
Key Technologies
- Artificial intelligence and advanced analytics
- Generative de-novo molecular design
- Cheminformatics and computational chemistry
- ADMET and pKi predictive modeling